Clinical Trial Update: Linperlisib in the Treatment of aPRCA [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating linperlisib for acquired pure red cell aplasia has not yet started recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Pure Red Cell Aplasia

Drugs mentioned

• Linperlisib (linperlisib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Acquired Pure Red Cell Aplasia | Phase 2 | Status: NOT_YET_RECRUITING